International audienceAdalimumab is a therapeutic antibody used for treating inflammatory diseases. To understand interindividual PK variability, there is a need to develop and validate an assay to measure serum adalimumab concentrations
Therapeutic drug monitoring (TDM) of biologics-encompassing the measurement of (trough) concentratio...
International audienceBackground: This study compared the performance of plasma infliximab and adali...
BACKGROUND AND AIM: Therapeutic drug monitoring is used to optimise adalimumab therapy in patients w...
International audienceAdalimumab is a therapeutic antibody used for treating inflammatory diseases. ...
Therapeutic drug monitoring of adalimumab (ADM) has been introduced recently. When no detectable ADM...
A number of assays are currently available to support therapeutic drug monitoring of adalimumab. A c...
With respect to patient safety and long-term efficacy, immunogenicity of therapeutic antibodies rema...
AbstractThis report describes the analytical validation and application of the homogeneous mobility ...
Aims: Development of a self-sampling method for therapeutic drug monitoring (TDM) of biologicals wil...
has been introduced recently. When no detectable ADM serum concentrations can be found, the formatio...
Llinares-Tello, F.; Gomez De Salazar, JR.; Senabre Gallego, JM.; Santos Soler, G.; Santos Ramírez, C...
International audienceAim: Ramucirumab, an anti-VEGFR2 monoclonal antibody, has been approved for th...
Biologic drugs have greatly improved treatment outcomes of inflammatory joint diseases, but a substa...
Antibody-based biopharmaceuticals have revolutionised treatment of inflammatory joint diseases in th...
Enabling Technology, Genomics, Proteomics Clinical Development Phases I-III Regulatory, Quality, Man...
Therapeutic drug monitoring (TDM) of biologics-encompassing the measurement of (trough) concentratio...
International audienceBackground: This study compared the performance of plasma infliximab and adali...
BACKGROUND AND AIM: Therapeutic drug monitoring is used to optimise adalimumab therapy in patients w...
International audienceAdalimumab is a therapeutic antibody used for treating inflammatory diseases. ...
Therapeutic drug monitoring of adalimumab (ADM) has been introduced recently. When no detectable ADM...
A number of assays are currently available to support therapeutic drug monitoring of adalimumab. A c...
With respect to patient safety and long-term efficacy, immunogenicity of therapeutic antibodies rema...
AbstractThis report describes the analytical validation and application of the homogeneous mobility ...
Aims: Development of a self-sampling method for therapeutic drug monitoring (TDM) of biologicals wil...
has been introduced recently. When no detectable ADM serum concentrations can be found, the formatio...
Llinares-Tello, F.; Gomez De Salazar, JR.; Senabre Gallego, JM.; Santos Soler, G.; Santos Ramírez, C...
International audienceAim: Ramucirumab, an anti-VEGFR2 monoclonal antibody, has been approved for th...
Biologic drugs have greatly improved treatment outcomes of inflammatory joint diseases, but a substa...
Antibody-based biopharmaceuticals have revolutionised treatment of inflammatory joint diseases in th...
Enabling Technology, Genomics, Proteomics Clinical Development Phases I-III Regulatory, Quality, Man...
Therapeutic drug monitoring (TDM) of biologics-encompassing the measurement of (trough) concentratio...
International audienceBackground: This study compared the performance of plasma infliximab and adali...
BACKGROUND AND AIM: Therapeutic drug monitoring is used to optimise adalimumab therapy in patients w...
DOI
Add to ORKG